Garner is a behavioral intervention scientist and an assistant professor of nutritional sciences.

Nasdaq’s determination is based on the Company meeting all other applicable requirements for listing on the Nasdaq Capital Market, with the exception of the bid price requirement, and the Company’s ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline ...

Strong enrollment activity to start 2025146 patients enrolled TORONTO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing ...

From the brink of Nasdaq delisting last year due to non-compliance with the minimum bid price rule, this clinical-stage biotechnology ...

Know Labs, Inc. (previously NYSE American: KNW, now OTC Markets: KNWN), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS), announced today it has ...

February is the month of love, and that should extend to the most important kind of love: self-love. What better way to show yourself some love than by taking care of your skin and body? This month's ...

Windtree Therapeutics Inc. (NASDAQ:WINT), a biotechnology company specializing in biological products, announced the outcome of two significant proposals voted on by shareholders at a Special Meeting ...

AbbVie (ABBV) said it has received FDA approval for the combination antibiotic treatment Emblaveo, which was co-developed ...

The FDA approved Susvimo for the treatment of diabetic macular edema, according to a press release. The decision was ...